Satyavrat Shukla

Satyavrat Shukla

Plus aucun poste en cours

Fortune : 99 149 $ au 31/08/2026

54 ans
Health Technology
Consumer Services
Commercial Services

Profil

Satyavrat Shukla worked at Cornerstone Research, Inc. as Principal from 2003 to 2012.
Then worked at Vertex Pharmaceuticals, Inc. as Vice President & Global Head-Corporate Finance from 2012 to 2019.
Worked at Alaunos Therapeutics, Inc. as Chief Financial Officer & Executive Vice President from 2019 to 2020.
Worked at Spero Therapeutics, Inc. as Director in 2025.
Education includes an undergraduate degree from Harvard University in 1993 and an MBA from Yale University in 1999.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
01/04/2026 81 270 ( 0,14% ) 99 149 $ 31/08/2026

Anciens postes connus de Satyavrat Shukla

SociétésPosteFin
SPERO THERAPEUTICS, INC. Directeur Général 10/01/2025
ALAUNOS THERAPEUTICS, INC. Directeur Financier/CFO 31/12/2020
VERTEX PHARMACEUTICALS INCORPORATED Corporate Officer/Principal 01/07/2019
Corporate Officer/Principal 01/01/2012
Voir l'expérience en détail de Satyavrat Shukla

Formation de Satyavrat Shukla

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

97

Relations au 1er degré

6

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées6

Health Technology

Consumer Services

Consumer Services

Commercial Services

Health Technology

Health Technology

  1. Bourse
  2. Insiders
  3. Satyavrat Shukla